title: Asymmetric dimethylarginine (ADMA): is really a biomarker for cardiovascular prognosis?
authors.forename: Dimitris
authors.initials: D
authors.lastname: Tousoulis
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Siasos
authors.forename: Evangelos
authors.initials: E
authors.lastname: Oikonomou
authors.forename: Pavlos
authors.initials: P
authors.lastname: Stougianos
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Papageorgiou
authors.forename: Athanasios G
authors.initials: AG
authors.lastname: Papavassiliou
authors.forename: Christodoulos
authors.initials: C
authors.lastname: Stefanadis
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood* / Q000401:mortality*; D017023:Coronary Angiography / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D012017:Referral and Consultation
chemical_list: C018524:N,N-dimethylarginine; D001120:Arginine